• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自同一位患者的两种卵巢腺癌细胞系中的细胞异质性和耐药性

Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient.

作者信息

Wolf C R, Hayward I P, Lawrie S S, Buckton K, McIntyre M A, Adams D J, Lewis A D, Scott A R, Smyth J F

出版信息

Int J Cancer. 1987 Jun 15;39(6):695-702. doi: 10.1002/ijc.2910390607.

DOI:10.1002/ijc.2910390607
PMID:3583449
Abstract

Two ovarian cell lines were derived from the ascites of a patient before and after the onset of resistance to chemotherapy involving cis-platinum, chlorambucil and 5-fluorouracil. Characterization of these lines shows them to have various features in common and some significant differences. Cytologically the lines cannot be distinguished and they both contain high concentrations of oestrogen receptor. However, they do differ with respect to their growth characteristics, karyotype, glutathione content and sensitivity to cis-platinum. The karyotypes of the 2 lines show several marker chromosomes in common but the resistant line contained a chromosome 8 and a 17 which were absent from the earlier sensitive line. This suggests a clonal origin with subsequent divergence to a heterogeneous population.

摘要

两种卵巢细胞系源自一名患者化疗耐药(涉及顺铂、苯丁酸氮芥和5-氟尿嘧啶)前后的腹水。对这些细胞系的特征分析表明,它们具有多种共同特征和一些显著差异。在细胞学上,这些细胞系无法区分,并且它们都含有高浓度的雌激素受体。然而,它们在生长特性、核型、谷胱甘肽含量和顺铂敏感性方面存在差异。这两种细胞系的核型显示有几条共同的标记染色体,但耐药细胞系含有一条8号染色体和一条17号染色体,而早期敏感细胞系中不存在这两条染色体。这表明它们起源于克隆,随后分化为异质群体。

相似文献

1
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient.源自同一位患者的两种卵巢腺癌细胞系中的细胞异质性和耐药性
Int J Cancer. 1987 Jun 15;39(6):695-702. doi: 10.1002/ijc.2910390607.
2
Comparative properties of five human ovarian adenocarcinoma cell lines.五种人卵巢腺癌细胞系的比较特性
Cancer Res. 1985 Aug;45(8):3668-76.
3
Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.具有雌激素和孕激素受体的人卵巢癌细胞系的特征分析
Cancer. 1989 Jan 15;63(2):280-8. doi: 10.1002/1097-0142(19890115)63:2<280::aid-cncr2820630213>3.0.co;2-n.
4
Cytogenetic evolution of human ovarian cell lines associated with chemoresistance and loss of tumorigenicity.与化疗耐药性和致瘤性丧失相关的人类卵巢细胞系的细胞遗传学演变。
Anal Cell Pathol. 2003;25(3):115-22. doi: 10.1155/2003/151042.
5
Cytogenetic findings in cell lines derived from four ovarian carcinomas.源自四种卵巢癌的细胞系的细胞遗传学发现。
Cancer Genet Cytogenet. 1987 Feb;24(2):231-42. doi: 10.1016/0165-4608(87)90104-x.
6
Establishment and characterization of ovarian endometrioid carcinoma cell line.卵巢子宫内膜样癌细胞系的建立与鉴定
Gynecol Oncol. 1984 Mar;17(3):314-25. doi: 10.1016/0090-8258(84)90217-8.
7
Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a rat ovarian carcinoma cell line.大鼠卵巢癌细胞系对顺二氯二氨铂(II)的耐药机制
Eur J Cancer Clin Oncol. 1989 Mar;25(3):429-37. doi: 10.1016/0277-5379(89)90255-1.
8
Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.新的雌激素受体阴性外阴癌细胞系UM-SCV-1A和UM-SCV-1B的表型特征、核型分析及体外他莫昔芬敏感性
Int J Cancer. 1990 May 15;45(5):920-7. doi: 10.1002/ijc.2910450524.
9
Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects.
Carcinogenesis. 1988 Jul;9(7):1283-7. doi: 10.1093/carcin/9.7.1283.
10
Generation of clonal variants in a human ovarian carcinoma studied by chromosome banding analysis.通过染色体显带分析研究人类卵巢癌中克隆变异体的产生。
Cancer Genet Cytogenet. 1985 Jan 1;14(1-2):153-61. doi: 10.1016/0165-4608(85)90226-2.

引用本文的文献

1
G-quadruplex structures regulate long-range transcriptional reprogramming to promote drug resistance in ovarian cancer cells.G-四链体结构调控远距离转录重编程以促进卵巢癌细胞的耐药性。
Genome Biol. 2025 Jul 12;26(1):183. doi: 10.1186/s13059-025-03654-y.
2
Deciphering the ghost proteome in ovarian cancer cells by deep proteogenomic characterization.通过深度蛋白质基因组特征分析破译卵巢癌细胞中的幽灵蛋白质组。
Cell Death Dis. 2024 Sep 30;15(9):712. doi: 10.1038/s41419-024-07046-1.
3
Cervical cancer: a tale from HPV infection to PARP inhibitors.
宫颈癌:从人乳头瘤病毒感染到聚(ADP - 核糖)聚合酶抑制剂的故事
Genes Dis. 2022 Nov 10;10(4):1445-1456. doi: 10.1016/j.gendis.2022.09.014. eCollection 2023 Jul.
4
Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy.源自铂耐药患者的高级别浆液性卵巢癌细胞系细胞外囊泡的特征作为辅助化疗反应预测的潜在工具
Pharmaceuticals (Basel). 2023 Jun 20;16(6):907. doi: 10.3390/ph16060907.
5
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics.通过空间分段单细胞转录组学揭示位置对细胞转录特性的影响。
Cell Syst. 2023 Jun 21;14(6):464-481.e7. doi: 10.1016/j.cels.2023.05.003.
6
Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells.Rho 激酶(ROCK)抑制剂在 BRCA2 缺陷细胞中诱导多种有丝分裂缺陷和合成致死。
Elife. 2023 Apr 19;12:e80254. doi: 10.7554/eLife.80254.
7
The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer.miRNA 毒性与非毒性比率可预测卵巢癌铂类敏感性
Cancer Res. 2021 Aug 1;81(15):3985-4000. doi: 10.1158/0008-5472.CAN-21-0953. Epub 2021 Jun 15.
8
Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells.I 型 PRMT 和 PARP 抑制剂对非小细胞肺癌细胞的协同作用。
Clin Epigenetics. 2021 Mar 10;13(1):54. doi: 10.1186/s13148-021-01037-1.
9
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade.人类卵巢癌内在机制调节淋巴细胞对免疫检查点阻断的激活。
Cancer Immunol Immunother. 2020 Aug;69(8):1391-1401. doi: 10.1007/s00262-020-02544-5. Epub 2020 Mar 21.
10
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.脂肪细胞诱导卵巢癌细胞中 FABP4 的表达促进转移并介导卡铂耐药性。
Cancer Res. 2020 Apr 15;80(8):1748-1761. doi: 10.1158/0008-5472.CAN-19-1999. Epub 2020 Feb 13.